2020 / 06

Next Paper
DOI: 10.24075/brsmu.2020.085

ORIGINAL RESEARCH

Interleukin dynamics during cognitive stress in patients with chronic cerebral ischemia

Fokin VF, Shabalina AA, Ponomareva NV, Medvedev RB, Lagoda OV, Tanashyan MM
About authors

Research Center of Neurology, Moscow, Russia

Correspondence should be addressed: Vitaly Fedorovich Fokin
Volokolamskoe shosse, 80, Moscow, 125367; ur.liam@fvf

About paper

Author contribution: Fokin VF performed data analysis and wrote the manuscript; Shabalina AA performed biochemical analysis of cytokines and participated in writing the manuscript; Ponomareva NV collected and analyzed psychometric data, participated in writing the manuscript; Medvedev RB performed clinical examinations, analyzed the literature and proposed the study design; Lagoda OV analyzed clinical data and proposed the study design; Tanashyan MM proposed the study design, summarized clinical data in the context of the obtained results.

Compliance with ethical standards: the study was approved by the Ethics Committee of the Research Center of Neurology (Protocol No. 11/14 dated November 19, 2014); all study participants signed informed consent to participate.

Received: 2020-11-06 Accepted: 2020-12-17 Published online: 2020-12-28
|
  1. Suslina ZA, Illarioshkin SN, Piradov MA. Nevrologija i nejronauki — prognoz razvitija. Annaly klinicheskoj i jeksperimental'noj nevrologii. 2007; 1 (1): 5–9. Russian.
  2. Fokin VF, Ponomareva NV, Androsova LV, Selezneva ND. Vzaimodejstvie nervnoj i immunnoj sistem pri normal'nom starenii i demencijah al'cgejmerovskogo tipa. Fiziologija cheloveka. 1996; 26 (6): 55–59. Russian.
  3. Ponomareva NV, Androsova LV, Klyushnikov SA, Abramycheva NYu, Malina DD, Filippova YuV, i dr. Narushenie nejro-immunnogo vzaimodejstvija na preklinicheskoj stadii bolezni Gentingtona i ego rol' v razvitii zabolevanija. Rukovodstvo dlja vrachej. V sbornike: Materialy HH Kongressa po nevrologii pod red. S. N. Illarioshkina i O. S. Levina. Moskva, 2017; s. 253–7. Russian.
  4. Huang ZB, Sheng GQ. Interleukin-1β with learning and memory. Neurosci Bull. 2010; 26 (6): 455–68. DOI: 10.1007/s12264-0106023-5.
  5. Erickson MA, Banks WA. Neuroimmune Axes of the Blood-Brain Barriers and Blood-Brain Interfaces: Bases for Physiological Regulation, Disease States, and Pharmacological Interventions. Pharmacol Rev. 2018; 70 (2): 278–314. DOI: 10.1124/pr.117.014647.
  6. Song C, Phillips AG, Leonard B. Interleukin 1 beta enhances conditioned fear memory in rats: possible involvement of glucocorticoids. Eur J Neurosci. 2003; 18: 1739–43. DOI: 10.1046/j.1460-9568.2003.02886.x.
  7. Haefeli WE, Bargetzi MJ, Starnes HF, Blaschke TF, Hoffman BB. Evidence for activation of the sympathetic nervous system by recombinant human interleukin-1 beta in humans. J Immunother Emphasis Tumor Immunol. 1993 Feb; 13 (2): 136–40. DOI: 10.1097/00002371-199302000-00009. PMID: 8318499.
  8. Erta M, Quintana A, Hidalgo J. Interleukin-6, a major cytokine in the central nervous system. Int J Biol Sci. 2012; 8 (9): 1254–66. DOI: 10.7150/ijbs.4679. Epub 2012 Oct 25. PMID: 23136554; PMCID: PMC3491449.
  9. Batysheva TT, Artemova IYu, Vdovichenko TV. Hronicheskaja ishemija mozga: mehanizmy razvitija i sovremennoe kompleksnoe lechenie. Consilium medicum 2004; 3 (4). Dostupno po ssylke: http://old.consilium-medicum.com/media/refer/04_04/51.shtml.Russian.
  10. Iadecola C, Alexander M. Cerebral ischemia and inflammation. Curr Opin Neurol. 2001 Feb; 14 (1): 89–94. DOI: 10.1097/00019052200102000-00014. PMID: 11176223.
  11. Sallmann S, Jüttler E, Prinz S, et al. Induction of Interleukin-6 by Depolarization of Neurons. Journal of Neuroscience 1 December 2000; 20 (23): 8637–42; DOI: 10.1523/ JNEUROSCI.20-23-08637.2000.
  12. Balschun D, Wetzel W, Del Rey A, Pitossi F, Schneider H, Zuschratter W, Besedovsky HO. Interleukin-6: a cytokine to forget. FASEB J. 2004 Nov; 18 (14): 1788–90. DOI: 10.1096/fj.041625fje. PMID: 15345694.
  13. Wright CB, Sacco RL, Rundek T, Delman J, Rabbani L, Elkind M. Interleukin-6 is associated with cognitive function: The Northern Manhattan Study. J Stroke Cerebrovasc Dis. 2006; 15 (1): 34–38. DOI: 10.1016/j.jstrokecerebrovasdis.2005.08.009.
  14. Helwig BG, Craig RA, Fels RJ, Blecha F, Kenney MJ. Central nervous system administration of interleukin-6 produces splenic sympathoexcitation. Auton Neurosci. 2008; 141 (1–2): 104–11. DOI: 10.1016/j.autneu.2008.04.008.
  15. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol. 2001; 19: 683–765.
  16. Henry C, Huang Y, Wynne AM, Godbout JP. Peripheral lipopolysaccharide (LPS) challenge promotes microglial hyperactivity in aged mice that is associated with exaggerated induction of both pro-inflammatory IL-1[beta] and antiinflammatory IL-10 cytokines. Brain Behav Immun. 2009; 23: 309.
  17. Woiciechowsky C, Schöning B, Lanksch WR, et al. Catecholamineinduced interleukin-10 release: a key mechanism in systemic immunodepression after brain injury. Crit Care. 1999; 3: R107. Available from: https://doi.org/10.1186/cc375.
  18. Kelly A, Lynch A, Vereker E, Nolan Y, Queenan P, Whittaker E, O'Neill LA, Lynch MA. The anti-inflammatory cytokine, interleukin (IL)-10, blocks the inhibitory effect of IL-1 beta on long term potentiation. A role for JNK. J Biol Chem. 2001 Dec 7; 276 (49): 45564–72. DOI: 10.1074/jbc.M108757200. PMID: 11581275.
  19. Levin OS. Discirkuljatornaja jencefalopatija: sovremennye predstavlenija o mehanizmah razvitija i lechenii. Consilium medicum. 2007; 8: 72–79. Russian.
  20. Tanashyan MM, Maksimova MYu, Domashenko MA. Discirkuljatornaja jencefalopatija. Putevoditel' vrachebnyh naznachenij. Terapevticheskij spravochnik. 2015; 2: 1–25. Russian.
  21. La Fratta I, Tatangelo R, Campagna G, et al. The plasmatic and salivary levels of IL-1β, IL-18 and IL-6 are associated to emotional difference during stress in young male. Sci Rep. 2018; 8 (1): 3031. DOI: 10.1038/s41598-018-21474-y. PMID: 29445205; PMCID: PMC5813044.
  22. Szabo YZ, Newton TL, Miller JJ, Lyle KB, Fernandez-Botran R. Acute stress induces increases in salivary IL-10 levels. Stress. 2016; 19 (5): 499–505. DOI: 10.1080/10253890.2016.1206885.
  23. Rezazadeh F, Shahbazi F, Andisheh-Tadbir A. Evaluation of salivary level of IL-10 in patients with oral lichen planus, a preliminary investigation. Comp Clin Pathol. 2017; 26: 531–4. Available from: https://doi.org/10.1007/s00580-017-2415-5.
  24. Nisticò R, Salter E, Nicolas C, et al. Synaptoimmunology — roles in health and disease. Mol Brain. 2017; 10: 26. Available from: https://doi.org/10.1186/s13041-017-0308-9.
  25. Liu F, Mccullough L. Inflammatory responses in hypoxic ischemic encephalopathy. Acta Pharmacol Sin. 2013; 34: 1121–30. Available from: https://doi.org/10.1038/aps.2013.89.
  26. März P, Cheng JG, Gadient RA, et al. Sympathetic neurons can produce and respond to interleukin 6. Proc Natl Acad Sci USA. 1998; 95 (6): 3251–6. DOI: 10.1073/pnas.95.6.3251.
  27. Liu X, Quan N. Microglia and CNS Interleukin-1: Beyond Immunological Concepts Front Neurol. 2018; 9: 8. DOI: 10.3389/ fneur.2018.00008.
  28. Gruol DL. IL-6 regulation of synaptic function in the CNS. Neuropharmacology. 2015 Sep; 96 (Pt A): 42–54. DOI: 10.1016/j.neuropharm.2014.10.023.
  29. Sparkman NL, Johnson RW. Neuroinflammation associated with aging sensitizes the brain to the effects of infection or stress. Neuroimmunomodulation. 2008; 15: 323–30.
  30. Lobo-Silva D, Carriche GM, Castro AG, et al. Balancing the immune response in the brain: IL-10 and its regulation. J Neuroinflammation. 2016; 13: 297. Available from: https://doi. org/10.1186/s12974-016-0763-8.